Ayuda
Ir al contenido

Dialnet


Resumen de Young blood

Sally Adee

  • Now start-ups, universities and pharmaceutical companies are clambering to commercialize the potential of young blood. Venture capitalists and high-level hospital executives are rumored to be partaking behind the scenes. The idea's popularity is sparking fears of red markets and a dystopian future in which the old steal youth from the young, and no longer just metaphorically. Here, Adee discusses a safer, more effective way for blood to stop the inevitable declines of ageing.


Fundación Dialnet

Dialnet Plus

  • Más información sobre Dialnet Plus